Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2018

Publisher Name :
Date: 19-Jun-2018
No. of pages: 96
Inquire Before Buying

This report studies the global Checkpoint Inhibitors for Treating Cancer market status and forecast, categorizes the global Checkpoint Inhibitors for Treating Cancer market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the "brakes" on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.

Those four kinds of checkpoint inhibitors are mainly used to treat melanoma, bladder cancer and others. In 2015, melanoma treatment consumed checkpoint inhibitors took a share of 80.53%. In 2016, melanoma treatment consumed checkpoint inhibitors will be 68153g. Bladder cancer treatment consumed checkpoint inhibitors will be 1978g.

Although YERVOY® (ipilimumab), OPDIVO® (nivolumab), KEYTRUDA® (pembrolizumab) and Tecentriq® (atezolizumab) are four indispensable medicines for cancer treatment, they also has many shortages. Firstly, they all have side effect for patient. Secondly, price of checkpoint inhibitors for treating cancer is too expensive. CTLA-4 inhibitors price is about 118.2 USD/mg in 2016. PD-1 inhibitors price is about 28.6 USD/mg in 2016. PD-L1 inhibitors price is about 30.5 USD/mg in 2016. For most patients, the price is unbearable.

The global Checkpoint Inhibitors for Treating Cancer market is valued at 4690 million US$ in 2017 and will reach 29000 million US$ by the end of 2025, growing at a CAGR of 25.6% during 2018-2025.

The major manufacturers covered in this report

- Bristol-Myers Squibb(BMS)

- Merck

- Roche

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

We can also provide the customized separate regional or country-level reports, for the following regions:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- - Rest of Europe

- Central & South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Saudi Arabia

- - Turkey

- - Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- PD-1 Inhibitors

- PD-L1 Inhibitors

- CTLA-4 Inhibitors

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

- Melanoma Treatment

- Bladder Cancer Treatment

- Other

The study objectives of this report are:

- To analyze and study the global Checkpoint Inhibitors for Treating Cancer sales, value, status (2013-2017) and forecast (2018-2025).

- Focuses on the key Checkpoint Inhibitors for Treating Cancer manufacturers, to study the sales, value, market share and development plans in future.

- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

- To define, describe and forecast the market by type, application and region.

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends and factors driving or inhibiting the market growth.

- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Checkpoint Inhibitors for Treating Cancer are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Checkpoint Inhibitors for Treating Cancer Manufacturers

Checkpoint Inhibitors for Treating Cancer Distributors/Traders/Wholesalers

Checkpoint Inhibitors for Treating Cancer Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Checkpoint Inhibitors for Treating Cancer market, by end-use.

Detailed analysis and profiles of additional market players.

Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2018

Table of Contents
Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2018
1 Checkpoint Inhibitors for Treating Cancer Market Overview
1.1 Product Overview and Scope of Checkpoint Inhibitors for Treating Cancer
1.2 Checkpoint Inhibitors for Treating Cancer Segment by Type (Product Category)
1.2.1 Global Checkpoint Inhibitors for Treating Cancer Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Checkpoint Inhibitors for Treating Cancer Production Market Share by Type (Product Category) in 2017
1.2.3 PD-1 Inhibitors
1.2.4 PD-L1 Inhibitors
1.2.5 CTLA-4 Inhibitors
1.3 Global Checkpoint Inhibitors for Treating Cancer Segment by Application
1.3.1 Checkpoint Inhibitors for Treating Cancer Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Melanoma Treatment
1.3.3 Bladder Cancer Treatment
1.3.4 Other
1.4 Global Checkpoint Inhibitors for Treating Cancer Market by Region (2013-2025)
1.4.1 Global Checkpoint Inhibitors for Treating Cancer Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Checkpoint Inhibitors for Treating Cancer (2013-2025)
1.5.1 Global Checkpoint Inhibitors for Treating Cancer Revenue Status and Outlook (2013-2025)
1.5.2 Global Checkpoint Inhibitors for Treating Cancer Capacity, Production Status and Outlook (2013-2025)
2 Global Checkpoint Inhibitors for Treating Cancer Market Competition by Manufacturers
2.1 Global Checkpoint Inhibitors for Treating Cancer Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Checkpoint Inhibitors for Treating Cancer Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Checkpoint Inhibitors for Treating Cancer Production and Share by Manufacturers (2013-2018)
2.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Share by Manufacturers (2013-2018)
2.3 Global Checkpoint Inhibitors for Treating Cancer Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Checkpoint Inhibitors for Treating Cancer Manufacturing Base Distribution, Sales Area and Product Type
2.5 Checkpoint Inhibitors for Treating Cancer Market Competitive Situation and Trends
2.5.1 Checkpoint Inhibitors for Treating Cancer Market Concentration Rate
2.5.2 Checkpoint Inhibitors for Treating Cancer Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Checkpoint Inhibitors for Treating Cancer Capacity and Market Share by Region (2013-2018)
3.2 Global Checkpoint Inhibitors for Treating Cancer Production and Market Share by Region (2013-2018)
3.3 Global Checkpoint Inhibitors for Treating Cancer Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Checkpoint Inhibitors for Treating Cancer Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Checkpoint Inhibitors for Treating Cancer Consumption by Region (2013-2018)
4.2 North America Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export, Import (2013-2018)
4.3 Europe Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export, Import (2013-2018)
4.4 China Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export, Import (2013-2018)
4.5 Japan Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export, Import (2013-2018)
4.7 India Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export, Import (2013-2018)
5 Global Checkpoint Inhibitors for Treating Cancer Production, Revenue (Value), Price Trend by Type
5.1 Global Checkpoint Inhibitors for Treating Cancer Production and Market Share by Type (2013-2018)
5.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Market Share by Type (2013-2018)
5.3 Global Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)
5.4 Global Checkpoint Inhibitors for Treating Cancer Production Growth by Type (2013-2018)
6 Global Checkpoint Inhibitors for Treating Cancer Market Analysis by Application
6.1 Global Checkpoint Inhibitors for Treating Cancer Consumption and Market Share by Application (2013-2018)
6.2 Global Checkpoint Inhibitors for Treating Cancer Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Checkpoint Inhibitors for Treating Cancer Manufacturers Profiles/Analysis
7.1 Bristol-Myers Squibb(BMS)
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Checkpoint Inhibitors for Treating Cancer Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Merck
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Checkpoint Inhibitors for Treating Cancer Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Merck Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Roche
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Checkpoint Inhibitors for Treating Cancer Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Roche Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
8 Checkpoint Inhibitors for Treating Cancer Manufacturing Cost Analysis
8.1 Checkpoint Inhibitors for Treating Cancer Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Checkpoint Inhibitors for Treating Cancer
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Checkpoint Inhibitors for Treating Cancer Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Checkpoint Inhibitors for Treating Cancer Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Checkpoint Inhibitors for Treating Cancer Market Forecast (2018-2025)
12.1 Global Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Checkpoint Inhibitors for Treating Cancer Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Checkpoint Inhibitors for Treating Cancer Price and Trend Forecast (2018-2025)
12.2 Global Checkpoint Inhibitors for Treating Cancer Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Checkpoint Inhibitors for Treating Cancer Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Checkpoint Inhibitors for Treating Cancer Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Checkpoint Inhibitors for Treating Cancer Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Checkpoint Inhibitors for Treating Cancer Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Checkpoint Inhibitors for Treating Cancer Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Checkpoint Inhibitors for Treating Cancer Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Checkpoint Inhibitors for Treating Cancer Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Checkpoint Inhibitors for Treating Cancer Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Checkpoint Inhibitors for Treating Cancer
Figure Global Checkpoint Inhibitors for Treating Cancer Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Production Market Share by Types (Product Category) in 2017
Figure Product Picture of PD-1 Inhibitors
Table Major Manufacturers of PD-1 Inhibitors
Figure Product Picture of PD-L1 Inhibitors
Table Major Manufacturers of PD-L1 Inhibitors
Figure Product Picture of CTLA-4 Inhibitors
Table Major Manufacturers of CTLA-4 Inhibitors
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption (g) by Applications (2013-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share by Applications in 2017
Figure Melanoma Treatment Examples
Table Key Downstream Customer in Melanoma Treatment
Figure Bladder Cancer Treatment Examples
Table Key Downstream Customer in Bladder Cancer Treatment
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Checkpoint Inhibitors for Treating Cancer Market Size (Million USD), Comparison (g) and CAGR (%) by Regions (2013-2025)
Figure North America Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity, Production (g) Status and Outlook (2013-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Major Players Product Capacity (g) (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Capacity (g) of Key Manufacturers (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity (g) of Key Manufacturers in 2017
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity (g) of Key Manufacturers in 2018
Figure Global Checkpoint Inhibitors for Treating Cancer Major Players Product Production (g) (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Production (g) of Key Manufacturers (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Production Share by Manufacturers (2013-2018)
Figure 2017 Checkpoint Inhibitors for Treating Cancer Production Share by Manufacturers
Figure 2017 Checkpoint Inhibitors for Treating Cancer Production Share by Manufacturers
Figure Global Checkpoint Inhibitors for Treating Cancer Major Players Product Revenue (Million USD) (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Manufacturers
Table 2018 Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Manufacturers
Table Global Market Checkpoint Inhibitors for Treating Cancer Average Price (USD/mg) of Key Manufacturers (2013-2018)
Figure Global Market Checkpoint Inhibitors for Treating Cancer Average Price (USD/mg) of Key Manufacturers in 2017
Table Manufacturers Checkpoint Inhibitors for Treating Cancer Manufacturing Base Distribution and Sales Area
Table Manufacturers Checkpoint Inhibitors for Treating Cancer Product Category
Figure Checkpoint Inhibitors for Treating Cancer Market Share of Top 3 Manufacturers
Figure Checkpoint Inhibitors for Treating Cancer Market Share of Top 5 Manufacturers
Table Global Checkpoint Inhibitors for Treating Cancer Capacity (g) by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity Market Share by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity Market Share by Region (2013-2018)
Figure 2017 Global Checkpoint Inhibitors for Treating Cancer Capacity Market Share by Region
Table Global Checkpoint Inhibitors for Treating Cancer Production by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Production (g) by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Production Market Share by Region (2013-2018)
Figure 2017 Global Checkpoint Inhibitors for Treating Cancer Production Market Share by Region
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) by Region (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Region (2013-2018)
Table 2017 Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Region
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity, Production (g) and Growth Rate (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Capacity, Production (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2013-2018)
Table North America Checkpoint Inhibitors for Treating Cancer Capacity, Production (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2013-2018)
Table Europe Checkpoint Inhibitors for Treating Cancer Capacity, Production (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2013-2018)
Table China Checkpoint Inhibitors for Treating Cancer Capacity, Production (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2013-2018)
Table Japan Checkpoint Inhibitors for Treating Cancer Capacity, Production (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2013-2018)
Table China Checkpoint Inhibitors for Treating Cancer Capacity, Production (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2013-2018)
Table Japan Checkpoint Inhibitors for Treating Cancer Capacity, Production (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Consumption (g) Market by Region (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share by Region (2013-2018)
Figure 2017 Global Checkpoint Inhibitors for Treating Cancer Consumption (g) Market Share by Region
Table North America Checkpoint Inhibitors for Treating Cancer Production, Consumption, Import & Export (g) (2013-2018)
Table Europe Checkpoint Inhibitors for Treating Cancer Production, Consumption, Import & Export (g) (2013-2018)
Table China Checkpoint Inhibitors for Treating Cancer Production, Consumption, Import & Export (g) (2013-2018)
Table Japan Checkpoint Inhibitors for Treating Cancer Production, Consumption, Import & Export (g) (2013-2018)
Table Southeast Asia Checkpoint Inhibitors for Treating Cancer Production, Consumption, Import & Export (g) (2013-2018)
Table India Checkpoint Inhibitors for Treating Cancer Production, Consumption, Import & Export (g) (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Production (g) by Type (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Production Share by Type (2013-2018)
Figure Production Market Share of Checkpoint Inhibitors for Treating Cancer by Type (2013-2018)
Figure 2017 Production Market Share of Checkpoint Inhibitors for Treating Cancer by Type
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) by Type (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Checkpoint Inhibitors for Treating Cancer by Type (2013-2018)
Figure 2017 Revenue Market Share of Checkpoint Inhibitors for Treating Cancer by Type
Table Global Checkpoint Inhibitors for Treating Cancer Price (USD/mg) by Type (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Production Growth by Type (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Consumption (g) by Application (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share by Application (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share by Applications (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share by Application in 2017
Table Global Checkpoint Inhibitors for Treating Cancer Consumption Growth Rate by Application (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption Growth Rate by Application (2013-2018)
Table Bristol-Myers Squibb(BMS) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Capacity, Production (g), Revenue (Million USD), Price (Bristol-Myers Squibb(BMS)) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Production Growth Rate (2013-2018)
Figure Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Production Market Share (2013-2018)
Figure Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Revenue Market Share (2013-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Checkpoint Inhibitors for Treating Cancer Capacity, Production (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2013-2018)
Figure Merck Checkpoint Inhibitors for Treating Cancer Production Growth Rate (2013-2018)
Figure Merck Checkpoint Inhibitors for Treating Cancer Production Market Share (2013-2018)
Figure Merck Checkpoint Inhibitors for Treating Cancer Revenue Market Share (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Checkpoint Inhibitors for Treating Cancer Capacity, Production (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2013-2018)
Figure Roche Checkpoint Inhibitors for Treating Cancer Production Growth Rate (2013-2018)
Figure Roche Checkpoint Inhibitors for Treating Cancer Production Market Share (2013-2018)
Figure Roche Checkpoint Inhibitors for Treating Cancer Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Checkpoint Inhibitors for Treating Cancer
Figure Manufacturing Process Analysis of Checkpoint Inhibitors for Treating Cancer
Figure Checkpoint Inhibitors for Treating Cancer Industrial Chain Analysis
Table Raw Materials Sources of Checkpoint Inhibitors for Treating Cancer Major Manufacturers in 2017
Table Major Buyers of Checkpoint Inhibitors for Treating Cancer
Table Distributors/Traders List
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity, Production (g) and Growth Rate Forecast (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Price (Million USD) and Trend Forecast (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Production (g) Forecast by Region (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Production Market Share Forecast by Region (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Consumption (g) Forecast by Region (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share Forecast by Region (2018-2025)
Figure North America Checkpoint Inhibitors for Treating Cancer Production (g) and Growth Rate Forecast (2018-2025)
Figure North America Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export and Import (g) Forecast (2018-2025)
Figure Europe Checkpoint Inhibitors for Treating Cancer Production (g) and Growth Rate Forecast (2018-2025)
Figure Europe Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export and Import (g) Forecast (2018-2025)
Figure China Checkpoint Inhibitors for Treating Cancer Production (g) and Growth Rate Forecast (2018-2025)
Figure China Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export and Import (g) Forecast (2018-2025)
Figure Japan Checkpoint Inhibitors for Treating Cancer Production (g) and Growth Rate Forecast (2018-2025)
Figure Japan Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export and Import (g) Forecast (2018-2025)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Production (g) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export and Import (g) Forecast (2018-2025)
Figure India Checkpoint Inhibitors for Treating Cancer Production (g) and Growth Rate Forecast (2018-2025)
Figure India Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export and Import (g) Forecast (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Production (g) Forecast by Type (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Production (g) Forecast by Type (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share Forecast by Type (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Price Forecast by Type (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Consumption (g) Forecast by Application (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption (g) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • Global and Chinese Checkpoint Inhibitors for Treating Cancer Industry, 2018 Market Research Report
    Published: 24-Jul-2018        Price: US 3000 Onwards        Pages: 142
    The 'Global and Chinese Checkpoint Inhibitors for Treating Cancer Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Checkpoint Inhibitors for Treating Cancer industry with a focus on the Chinese market. The report provides key statistics on the market status of the Checkpoint Inhibitors for Treating Cancer manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Fir......
  • Colorectal Cancer Diagnostic Market with Focus on DNA-Based Tests: Industry Analysis & Outlook (2018-2025)
    Published: 23-Jul-2018        Price: US 1100 Onwards        Pages: 86
    Colorectal cancer, also known as bowel cancer and colon cancer, is the development of the cancer in the colon or rectum. A cancer is the abnormal growth of the cells that have the ability to invade or spread to the other parts of the body. Colorectal cancer begins when the healthy cells in the lining of the colon or rectum changes and grows out of control, forming a mass called tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other p......
  • Global and Chinese Cancer/Tumor Profiling Industry, 2018 Market Research Report
    Published: 22-Jul-2018        Price: US 3000 Onwards        Pages: 141
    The 'Global and Chinese Cancer/Tumor Profiling Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Cancer/Tumor Profiling industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer/Tumor Profiling manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industr......
  • Global and Chinese Solid Tumor Testing Industry, 2018 Market Research Report
    Published: 21-Jul-2018        Price: US 3000 Onwards        Pages: 149
    The 'Global and Chinese Solid Tumor Testing Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Solid Tumor Testing industry with a focus on the Chinese market. The report provides key statistics on the market status of the Solid Tumor Testing manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry includi......
  • Global Checkpoint Inhibitors for Treating Cancer Market Professional Survey Report 2018
    Published: 18-Jul-2018        Price: US 3500 Onwards        Pages: 103
    This report studies the global Checkpoint Inhibitors for Treating Cancer market status and forecast, categorizes the global Checkpoint Inhibitors for Treating Cancer market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Checkpoint inhibitors for treating cancer is a type of drug tha......
  • 2018-2023 Global Checkpoint Inhibitors for Treating Cancer Consumption Market Report
    Published: 17-Jul-2018        Price: US 4660 Onwards        Pages: 130
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Checkpoint Inhibitors for Treating Cancer market for 2018-2023. Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are ......
  • 2018 Top 5 Checkpoint Inhibitors for Treating Cancer Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 17-Jul-2018        Price: US 4960 Onwards        Pages: 125
    Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the "brakes" on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1......
  • Global Pap Tests and HPV Tests Market Professional Survey Report 2018
    Published: 10-Jul-2018        Price: US 3500 Onwards        Pages: 100
    This report studies the global Pap Tests and HPV Tests market status and forecast, categorizes the global Pap Tests and HPV Tests market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). The global Pap Tests and HPV Tests market is valued at million US$ in 2017 and will reach million U......
  • Global Prostate Cancer Diagnostics Market Professional Survey Report 2018
    Published: 02-Jul-2018        Price: US 3500 Onwards        Pages: 116
    This report studies the global Prostate Cancer Diagnostics market status and forecast, categorizes the global Prostate Cancer Diagnostics market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). The prostate is a walnut-sized gland located behind the base of a man's penis, in front of ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs